CPRT:NASDAQCopart, Inc. Analysis

Copart’s stock is trading at $37.57, just below its 20‑day SMA of 37.68 and well under the 50‑day SMA of 39.03, indicating short‑term weakness. The 30‑day volatility of 34% and a decreasing volume trend signal heightened price swings and waning buying pressure. Although the RSI sits near the mid‑range at 45.5, the MACD histogram is positive (0.16) despite a negative MACD line, suggesting a tentative bullish reversal. The stock’s beta of 0.57 points to lower market‑wide risk, yet the overall trend remains bearish. Valuation metrics show a PE of 23.6x versus an industry average of 29.5x, and a DCF‑derived fair value of $19.96, implying the market is pricing the shares at a premium. The upside/downside estimate of +13.6% aligns with analyst targets that sit near $44, hinting at modest upside potential.
Recent earnings disclosed a 3.6% revenue decline to $1.12 bn and GAAP EPS of $0.36, missing consensus expectations. The miss was offset by a robust operating margin of 34.7% and free cash flow exceeding $1 bn, underscoring the business’s cash generation strength. A newly secured $1.25 bn unsecured revolving credit facility enhances liquidity and provides a cushion for strategic investments. The company’s global footprint across North America, Europe, and the Middle East diversifies geographic exposure, though a modest geographic risk rating remains. With no dividend and a payout ratio of zero, investors are reliant on price appreciation driven by operational performance. In sum, Copart’s strong balance sheet and attractive margins support a medium‑term buy case, while technical softness tempers short‑term enthusiasm.